U.K. Cell Penetrating Peptide Market, 2023-2030
The cell penetrating peptide market in the UK is expected to reach a projected revenue of US$ 126.5 million by 2030. A compound annual growth rate of 10.8% is expected of the UK cell penetrating peptide market from 2024 to 2030.
Revenue, 2023 (US$M)
$61.8
Forecast, 2030 (US$M)
$126.5
CAGR, 2024 - 2030
10.8%
Report Coverage
UK
U.K. Cell Penetrating Peptide Market, 2018-2030 (US$M)
Global Market
Related Markets
UK cell penetrating peptide market highlights
- The UK cell penetrating peptide market generated a revenue of USD 61.8 million in 2023 and is expected to reach USD 126.5 million by 2030.
- The UK market is expected to grow at a CAGR of 10.8% from 2024 to 2030.
- In terms of segment, synthetic cpps was the largest revenue generating type in 2023.
- Protein-Derived CPPs is the most lucrative type segment registering the fastest growth during the forecast period.
Cell penetrating peptide market data book summary
| Market revenue in 2023 | USD 61.8 million |
| Market revenue in 2030 | USD 126.5 million |
| Growth rate | 10.8% (CAGR from 2023 to 2030) |
| Largest segment | Synthetic cpps |
| Fastest growing segment | Protein-Derived CPPs |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Protein-Derived CPPs, Synthetic CPPs, Chimeric CPPs |
| Key market players worldwide | Biosynth, Creative Peptides, Cupid Peptides, Alta Bioscience Ltd, AnaSpec, Peptomyc, Sarepta Therapeutics Inc, Revance Therapeutics Inc, PolyPeptide Group AG, Bachem Holding AG |
Other key industry trends
- In terms of revenue, UK accounted for 4.2% of the global cell penetrating peptide market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany cell penetrating peptide market is projected to lead the regional market in terms of revenue in 2030.
- Denmark is the fastest growing regional market in Europe and is projected to reach USD 7.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Three ways to get this data
Subscribe to the databook, customize it, or ask a question.Horizon Databook
Unlock every chart on this page and get dashboard access
- Statistics1.2M+ across all markets
- Databooks30K+ global, 120K+ country
- Companies200K+ profiles
- ExportPDF, Dashboard, XLS & PNG, licensed to cite
Customize it
Customize data as per your requirement
- AddCountries, segments, years
- RecutTo your product definition
- ExtendCompany-level detail
- OrA bespoke databook
- Turnaround5–10 working days
Ask Prism AI
A cited answer in seconds
- Corpus30,000 studies, 1.2M points
- ScopeAll markets, not just this
- CitationTraced to report & table
- HonestySays "not covered" if so
- SpeedSeconds, not days
Cell Penetrating Peptide Market Report
Cell penetrating peptide market report segmentation & scope
Cell Penetrating Peptide Market Report Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Revance Therapeutics Inc | View profile | 597 | 1222 Demonbreun Street, Suite 2000, Nashville, TN, United States, 37203 | www.revance.com |
| PolyPeptide Group AG | View profile | 1,273 | Neuhofstrasse 24, Baar, Zug, Switzerland, 6340 | www.polypeptide.com |
| Bachem Holding AG | View profile | 2,006 | Hauptstrasse 144, Bubendorf, Switzerland, 4416 | www.bachem.com |
| Creative Peptides | View profile | 1-10 | New York, New York, United States, North America | www.creative-peptides.com/index.html |
| Sarepta Therapeutics Inc | View profile | 1,314 | 215 First Street, Suite 415, Cambridge, MA, United States, 02142 | www.sarepta.com |
| Biosynth | View profile | 501-1000 | Saint Gallen, Sankt Gallen, Switzerland, Europe | www.biosynth.com |
| Cupid Peptides | View profile | 1-10 | Cardiff, Cardiff, United Kingdom, Europe | cupidpeptides.com |
| Alta Bioscience Ltd | View profile | 11-50 | Redditch, Worcestershire, United Kingdom, Europe | altabioscience.com |
| AnaSpec | View profile | 51-100 | Fremont, California, United States, North America | www.anaspec.com |
| Peptomyc | View profile | 11-50 | Barcelona, Catalonia, Spain, Europe | www.peptomyc.com/ |
U.K. cell penetrating peptide market report
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Cell Penetrating Peptide Market will help companies and investors design strategic landscapes.
Synthetic Cpps was the largest segment with a revenue share of 54.85% in 2023.
Horizon Databook has segmented the U.K. cell penetrating peptide market based on protein-derived cpps, synthetic cpps, chimeric cpps covering the revenue growth of each sub-segment from 2018 to 2030.
- U.K. Cell Penetrating Peptide Market Type Outlook (Revenue, USD Million , 2018-2030)
- Protein-Derived CPPs
- Synthetic CPPs
- Chimeric CPPs
- U.K. Cell Penetrating Peptide Market Application Outlook (Revenue, USD Million , 2018-2030)
- Drug Delivery
- Gene Delivery
- Diagnostics
- Molecular Imaging
- Other Applications
- U.K. Cell Penetrating Peptide Market End-use Outlook (Revenue, USD Million , 2018-2030)
- Pharmaceutical & Biotechnology Companies
- Contract Research Organization (CROs)
- Hospitals & Clinics
- Other End-users
Reasons to subscribe to cell penetrating peptide market report databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of cell penetrating peptide market report databook
- Our clientele includes a mix of cell penetrating peptide market report companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.K. cell penetrating peptide market report, including forecasts for subscribers. This country databook contains high-level insights into U.K. cell penetrating peptide market report from 2018 to 2030, including revenue numbers, major trends, and company profiles.
U.K. Cell Penetrating Peptide Market, 2018-2030 (US$M)
UK cell penetrating peptide market report statistics, by type, 2018-2030 (US$M)
